ARTICLE | Company News
FTA Bioscience, Pure Bioscience deal
August 9, 2010 7:00 AM UTC
Pure Bioscience granted FTA exclusive, worldwide rights to develop and commercialize a topical silver dihydrogen citrate (SDC)-based product for onychomycosis and tinea pedis (athlete's foot). The ele...